» Articles » PMID: 17596284

Foxa1 and Foxa2 Regulate Multiple Phases of Midbrain Dopaminergic Neuron Development in a Dosage-dependent Manner

Overview
Journal Development
Specialty Biology
Date 2007 Jun 29
PMID 17596284
Citations 140
Authors
Affiliations
Soon will be listed here.
Abstract

The role of transcription factors in regulating the development of midbrain dopaminergic (mDA) neurons is intensively studied owing to the involvement of these neurons in diverse neurological disorders. Here we demonstrate novel roles for the forkhead/winged helix transcription factors Foxa1 and Foxa2 in the specification and differentiation of mDA neurons by analysing the phenotype of Foxa1 and Foxa2 single- and double-mutant mouse embryos. During specification, Foxa1 and Foxa2 regulate the extent of neurogenesis in mDA progenitors by positively regulating Ngn2 (Neurog2) expression. Subsequently, Foxa1 and Foxa2 regulate the expression of Nurr1 (Nr4a2) and engrailed 1 in immature neurons and the expression of aromatic l-amino acid decarboxylase and tyrosine hydroxylase in mature neurons during early and late differentiation of midbrain dopaminergic neurons. Interestingly, genetic evidence indicates that these functions require different gene dosages of Foxa1 and Foxa2. Altogether, our results demonstrate that Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner.

Citing Articles

State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons.

Basso V, Dobrossy M, Thompson L, Kirik D, Fuller H, Gates M Biology (Basel). 2024; 13(9).

PMID: 39336117 PMC: 11428604. DOI: 10.3390/biology13090690.


Uncovering the role of the subcommissural organ in early brain development through transcriptomic analysis.

Gonzalez M, Maurelia F, Aguayo J, Amigo R, Arrue R, Gutierrez J Biol Res. 2024; 57(1):49.

PMID: 39068496 PMC: 11282827. DOI: 10.1186/s40659-024-00524-y.


FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer.

Liu N, Wang A, Xue M, Zhu X, Liu Y, Chen M Cell Death Discov. 2024; 10(1):172.

PMID: 38605023 PMC: 11009302. DOI: 10.1038/s41420-024-01936-1.


Midbrain organoids-development and applications in Parkinson's disease.

Toh H, Choo X, Sun A Oxf Open Neurosci. 2024; 2:kvad009.

PMID: 38596240 PMC: 10913847. DOI: 10.1093/oons/kvad009.


Inhibition of 7α,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron development.

Hennegan J, Bryant A, Griffiths L, Trigano M, Bartley O, Bartlett J iScience. 2023; 27(1):108670.

PMID: 38155767 PMC: 10753067. DOI: 10.1016/j.isci.2023.108670.